The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Neurological Diseases in Relation to the Blood–Brain Barrier
Open accessAbstract
Disruption of the blood–brain barrier (BBB) has an important part in cellular damage in neurological diseases, including acute and chronic cerebral ischemia, brain trauma, multiple sclerosis, brain tumors, and brain infections. The neurovascular unit (NVU) forms the interface between the blood and brain tissues. During an injury, the cascade of molecular events ends in the final common pathway for BBB disruption by free radicals and proteases, which attack membranes and degrade the tight junction proteins in endothelial cells. Free radicals of oxygen and nitrogen and the proteases, matrix metalloproteinases and cyclooxgyenases, are important in the early and delayed BBB disruption as the neuroinflammatory response progresses. Opening of the BBB occurs in neurodegenerative diseases and contributes to the cognitive changes. In addition to the importance of the NVU in acute injury, angiogenesis contributes to the recovery process. The challenges to treatment of the brain diseases involve not only facilitating drug entry into the brain, but also understanding the timing of the molecular cascades to block the early NVU injury without interfering with recovery. This review will describe the molecular and cellular events associated with NVU disruption and potential strategies directed toward restoring its integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707534 · Cited by 1,255
Silent brain infarcts: a systematic review
Vermeer, S. E., Longstreth, W. T., & Koudstaal, P. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70170-9 · Cited by 1,221
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Self-citationapoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587
Research works printed but not linked: 54
- 10.1161/STROKEAHA.110.591362 · DOI
- 10.1161/01.STR.28.1.1 · DOI · Paper page
- 10.1002/glia.20169 · DOI · Paper page
- 10.1017/S0080456800027174 · DOI · Paper page
- 10.2174/138161208784705469 · DOI · Paper page
- 10.1002/mrm.10524 · DOI
- 10.1161/STROKEAHA.110.582601 · DOI
- 10.1097/00005072-196307000-00011 · DOI
- 10.1212/WNL.0b013e3182143577 · DOI
- 10.1083/jcb.141.7.1539 · DOI · Paper page
- 10.1016/j.brainres.2007.04.044 · DOI · Paper page
- 10.1093/brain/awm228 · DOI · Paper page
- 10.1227/01.NEU.0000351768.11363.48 · DOI
- 10.1523/JNEUROSCI.4555-04.2005 · DOI
- 10.1002/ana.21800 · DOI · Paper page
- 10.1038/sj.jcbfm.9600598 · DOI
- 10.3171/2010.6.JNS10207 · DOI · Paper page
- 10.1242/jcs.110.14.1603 · DOI · Paper page
- 10.3174/ajnr.A2244 · DOI
- 10.1038/nrd2308 · DOI · Paper page
- 10.1038/nn2003 · DOI · Paper page
- 10.1016/j.jneuroim.2011.01.009 · DOI
- 10.1523/JNEUROSCI.23-25-08733.2003 · DOI
- 10.1007/BF00688633 · DOI · Paper page
- 10.1212/01.wnl.0000277487.04281.db · DOI · Paper page
- 10.1016/S0022-510X(02)00421-5 · DOI · Paper page
- 10.1016/S0165-0173(01)00101-1 · DOI · Paper page
- 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · doi:10.1002/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q
- 10.1186/1471-2202-10-126 · DOI
- 10.1111/j.1471-4159.2008.05582.x · DOI · Paper page
- 10.1056/NEJMoa020696 · DOI · Paper page
- 10.1161/STROKEAHA.107.486134 · DOI
- 10.1161/hs1201.99512 · DOI · Paper page
- 10.1097/00004647-199911000-00005 · DOI
- 10.1038/nrn2995 · DOI · Paper page
- Paterson PY, 1976, Fed Proc, 35, 2428
- 10.1038/jcbfm.1983.1 · DOI · Paper page
- 10.1001/archneurpsyc.1937.02260190011001 · doi:10.1001/archneurpsyc.1937.02260190011001
- 10.1523/JNEUROSCI.3467-10.2010 · DOI · Paper page
- 10.1212/WNL.46.6.1626 · DOI · Paper page
- 10.1161/01.STR.29.10.2189 · DOI · Paper page
- 10.1161/01.STR.32.5.1162 · DOI · Paper page
- 10.1161/ATVBAHA.108.181644 · DOI
- 10.1212/WNL.50.4.966 · DOI
- 10.1038/nn1676 · DOI
- 10.1212/WNL.0b013e31820b7630 · DOI
- Tan IL, 2000, AJNR, 21, 1039
- 10.7326/0003-4819-109-1-41 · DOI
- 10.1111/j.1600-0404.1990.tb01562.x · DOI
- 10.1212/01.wnl.0000275230.20635.72 · DOI
- 10.1002/jcp.21537 · DOI · Paper page
- 10.1016/S0079-6123(06)61012-1 · DOI
- 10.1038/nm1387 · DOI · Paper page
- 10.1038/nm1210-1370 · DOI · Paper page
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“Consistent with this hypothesis, postmortem studies have shown that areas of leukoaraiosis are chronically hypoxic, as indicated by the expression of hypoxia inducible factors and related hypoxia-inducible genes (Fernando et al., 2006; Rosenberg et al., 2001).”
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
“CT could be a tool to assess the risk of hemorrhage before the tPA treatment [92].”
MethodIadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746
Brain metabolism in health, aging, and neurodegeneration
Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“Mechanisms leading to BBB leakage in aging brains are complex, including oxidative damage and the activation of proteases, matrix metalloproteinases, and cyclooxygenases [131].”
Background
Metadata
- Authors
- Rosenberg, G. A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2012-01-18
- Volume
- 32
- Issue
- 7
- Pages
- 1139-1151
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2082121172
- Cited by
- 445
- References
- 17
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurological Diseases in Relation to the Blood–Brain Barrier. https://app.cochat.ai/papers/10.1038/jcbfm.2011.197
- The paper
- Rosenberg, G. A. (2012). Neurological Diseases in Relation to the Blood–Brain Barrier. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1038/jcbfm.2011.197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
